Novitium Drug Patent Portfolio
Novitium owns 2 orange book drugs protected by 3 US patents Given below is the list of Novitium's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11878022 | Hydrochlorothiazide compositions | 23 Jan, 2044 | Active |
| US11224572 | Stable oral liquid composition of terazosin | 01 Feb, 2041 | Active |
| US12427108 | Stable Oral Liquid Composition Of Terazosin | 01 Feb, 2041 | Active |
Latest Legal Activities on Novitium's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Novitium.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Dispatch to FDC | 11 Sep, 2025 | US12427108 |
| Application Is Considered Ready for Issue | 11 Sep, 2025 | US12427108 |
| Issue Fee Payment Verified | 09 Sep, 2025 | US12427108 |
| Issue Fee Payment Received | 09 Sep, 2025 | US12427108 |
| Mail Notice of Allowance | 18 Jul, 2025 | US12427108 |
| Email Notification | 18 Jul, 2025 | US12427108 |
| Notice of Allowance Data Verification Completed | 17 Jul, 2025 | US12427108 |
| Date Forwarded to Examiner | 18 Jun, 2025 | US12427108 |
| Response after Non-Final Action | 13 Jun, 2025 | US12427108 |
| Electronic Review | 03 Jun, 2025 | US12427108 |
| Email Notification | 03 Jun, 2025 | US12427108 |
| Mail Non-Final Rejection | 03 Jun, 2025 | US12427108 |
| Non-Final Rejection | 30 May, 2025 | US12427108 |
| Date Forwarded to Examiner | 07 May, 2025 | US12427108 |
| Disposal for a RCE / CPA / R129 | 07 May, 2025 | US12427108 |
Novitium's Family Patents
Novitium Drug List
Given below is the complete list of Novitium's drugs and the patents protecting them.
1. Inzirqo
Inzirqo is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11878022 | Hydrochlorothiazide compositions |
23 Jan, 2044
(17 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Inzirqo's drug page
2. Tezruly
Tezruly is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11224572 | Stable oral liquid composition of terazosin |
01 Feb, 2041
(14 years from now)
| Active |
| US12427108 | Stable Oral Liquid Composition Of Terazosin |
01 Feb, 2041
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tezruly's drug page